Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer. | Mol Cancer | 2022 | 35081970 | PubTator, text mining | PubMed |
| The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target. | J Oncol | 2022 | 35069735 | PubTator, text mining | PubMed |
| The Emerging Role of Non-Coding RNAs in the Regulation of Virus Replication and Resultant Cellular Pathologies. | Int J Mol Sci | 2022 | 35055001 | PubTator, text mining | PubMed |
| FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target? | Life (Basel) | 2022 | 35054474 | PubTator, text mining | PubMed |
| Identification and Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma. | Cancers (Basel) | 2022 | 35053583 | PubTator, text mining | PubMed |
| Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | Mol Syst Biol | 2022 | 35044719 | PubTator, text mining | PubMed |
| Sequential stabilization of RNF220 by RLIM and ZC4H2 during cerebellum development and Shh-group medulloblastoma progression. | J Mol Cell Biol | 2022 | 35040952 | PubTator, text mining | PubMed |
| How can same-gene mutations promote both cancer and developmental disorders? | Sci Adv | 2022 | 35030014 | PubTator, text mining | PubMed |
| Human telomerase reverse transcriptase promotes the epithelial to mesenchymal transition in lung cancer cells by enhancing c-MET upregulation. | Heliyon | 2022 | 35024489 | PubTator, text mining | PubMed |
| Integrated Proteomics-Based Physical and Functional Mapping of AXL Kinase Signaling Pathways and Inhibitors Define Its Role in Cell Migration. | Mol Cancer Res | 2022 | 35022314 | PubTator, text mining | PubMed |
| Towards targeting of shared mechanisms of cancer metastasis and therapy resistance. | Nat Rev Cancer | 2022 | 35013601 | PubTator, text mining | PubMed |
| Co-Expression Analysis of microRNAs and Proteins in Brain of Alzheimer's Disease Patients. | Cells | 2022 | 35011725 | PubTator, text mining | PubMed |
| Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers. | Curr Res Pharmacol Drug Discov | 2022 | 35005612 | PubTator, text mining | PubMed |
| A combined risk model for the multi-encompassing identification of heterogeneities of prognoses, biological pathway variations and immune states for sepsis patients. | BMC Anesthesiol | 2022 | 34996374 | PubTator, text mining | PubMed |
| Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities. | Theranostics | 2022 | 34987644 | PubTator, text mining | PubMed |
| MicroRNA expression signature and target prediction in familial and sporadic primary macronodular adrenal hyperplasia (PMAH). | BMC Endocr Disord | 2022 | 34986816 | PubTator, text mining | PubMed |
| Multiomics analysis identifies BIRC3 as a novel glucocorticoid response-associated gene. | J Allergy Clin Immunol | 2022 | 34971648 | PubTator, text mining | PubMed |
| Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications. | ACS Chem Biol | 2022 | 34941261 | PubTator, text mining | PubMed |
| Macromolecular Crowding Induces a Binding Competent Transient Structure in Intrinsically Disordered Gab1. | J Mol Biol | 2022 | 34929201 | PubTator, text mining | PubMed |
| Comparisons of the immunological landscape of COVID-19 patients based on sex and disease severity by multi-omics analysis. | Chem Biol Interact | 2022 | 34896122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=25